Tools   Select Another Resource Report Type

http://www.neurotechindustry.org/

The Neurotechnology Industry Organization (NIO) is a non-profit trade association that represents companies involved in neuroscience (neuropharmaceuticals, cell-based therapeutics, neurodevices and neurodiagnostics), academic neuroscience research centers, and brain-illness advocacy groups across the United States and throughout the world. NIO was formed to provide a unified voice for the commerical neuroscience community. NIO advocates for its member organizations on a range of issues related to neurotechnology research and business development including favorable changes in the tax code, intellectual property issues, neuroethics, public policy, reimbursement and patient advocacy. Thank you for taking the time to read this brief introduction to the Neurotechnology Industry Organization (NIO), the recently formed trade association representing companies involved in neuroscience (drugs, devices and diagnostics), brain research centers, patient advocacy groups, and research foundations worldwide. NIO was founded in August 2006 and has attracted over 80 member organizations. NIO''s mission is to accelerate treatments and cures for brain and nervous system illnesses by: * Advocating neurotech''s position to government and regulatory officials * Promoting the industry''s progress and contributions to quality of life * Providing industry development services for our members NIO is spearheading several innovative programs that will benefit your company including: National Neurotechnology Initiative - a new $200M/year Federal initiative aimed at accelerating translational neuroscience innovation and improving the effectiveness of the FDA review process for neuroscience drugs, devices and diagnostics NIO/FDA private-public working group - an initiative to work collaboratively with the FDA to improve the efficiency of the evaluation process for neuroscience products and to increase communication and clarity during the regulatory process Partnering, investment and policy events - networking events with other members of the global commercial neuroscience community at events such as the annual public policy tour in March in Washington D.C. and the Neurotech investing and partnering conference in Spring National Visibility - NIO actively outreaches to global media outlets to encourage coverage of Neurotech that will foster great investor, policymaker and consumer interest. As a member of NIO you will enjoy the following benefits: * Influence in the industry''s overall development agenda * Access to key opinion leaders in Congress, regulatory agencies, media * Participation in FDA and CMS working groups, stakeholder meetings * Expanded networking at neurotech investing and partnering events throughout the year * Participation in neuroscience education awareness initiatives, public awareness campaigns * Industry leadership through participation in driving innovative legislation, new projects NIO''s programs increase awareness of commercial neuroscience products, reduce barriers to innovation, support industry growth and will benefit your company and industry. I hope that you will consider joining NIO in support of our mission to give the brain a voice..

Proper citation: Neurotechnology Industry Organization (RRID:SCR_006556) Copy   

•   Source: SciCrunch Registry
  

http://www.autopack.org/

A specialized version of autoPack designed to pack biological components together. The current version is optimized to pack molecules into cells with biologically relevant interactions to populate massive cell models with atomic or near-atomic details. Components of the algorithm pack transmembrane proteins and lipids into bilayers, globular molecules into compartments defined by the bilayers (or as exteriors), and fibrous components like microtubules, actin, and DNA.

Proper citation: Cellpack (RRID:SCR_006831) Copy   

•   Source: SciCrunch Registry
  

http://1mind4research.org/

One Mind for Research''s plan to work smarter and share resources through public and private partnerships has the power to help us make more progress on every brain disorder from schizophrenia to traumatic brain injury. In the process, we will increase the investment in research by $1.5 billion each year for the next 10 years. And achieve a minimum 10% reduction in the cost of brain disease per year. This is how neurological cures that once seemed beyond our reach begin to take shape. When we''re all of one mind working toward the same goal, anything can be accomplished. $8 billion a year is spent on brain research, but the minimum cost of brain disease is one hundred times that. Yet amazingly, unlocking the mysteries of the human brain has less to do with resources than it does their coordination. Because though there is science, it exists in many different silos. There has never been a single organization that brings together the science, technology, financial resources and knowledge required to create an unprecedented understanding of brain disease. Until now. The One Mind for Research Forum began on May 23, 2011 and over the course of 2 days, the best and brightest from around the world gathered as part of a national collaboration of research universities, scientists, and the National Institutes of Health (NIH) Directors as they imagined an ambitious 10-year plan for neuroscience research. One Mind believes that new treatments and cures for neurological and psychiatric diseases that afflict one in three Americans, from children with autism to senior citizens with Alzheimer''s disease, are all within reach.

Proper citation: One Mind for Research (RRID:SCR_006711) Copy   

•   Source: SciCrunch Registry
  

http://soap.genomics.org.cn/soapaligner.html

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on April 12,2024. Updated version of SOAP software for short oligonucleotide alignment that features in super fast and accurate alignment for huge amounts of short reads generated by Illumina/Solexa Genome Analyzer., THIS RESOURCE IS NO LONGER IN SERVICE. Documented on September 16,2025.

Proper citation: SOAPaligner/soap2 (RRID:SCR_005503) Copy   

•   Source: SciCrunch Registry
  

http://www.genboree.org/epigenomeatlas/index.rhtml

Collection of human reference epigenomes and results of their integrative and comparative analyses. Successive releases of the Atlas will provide progressively more detailed insights into locus-specific epigenomic states, including histone marks and DNA methylation marks across specific tissues and cell types, developmental stages, physiological conditions, genotypes, and disease states. The Human Epigenome Atlas is produced by the NIH Epigenomics Roadmap Consortium.

Proper citation: Human Epigenome Atlas (RRID:SCR_006153) Copy   

•   Source: SciCrunch Registry
  

http://www.neurodevnet.ca/

NeuroDevNet, a Canadian Network of Centres of Excellence (NCE), is dedicated to helping children overcome neurodevelopmental disorders. Network investigators seek to understand the causes of neurological deficits, and to transfer this knowledge to health care professionals, policy makers, and communities of interest. NeuroDevNet works with its partners in academia, the community, not-for-profit sector, industry, and government, and across traditional disciplinary boundaries and sectors, to ensure generated knowledge is translated into tangible diagnostic, preventative, therapeutic, social, economic, and health benefits for all. NeuroDevNet supports transformative research, provides training to build a new generation of Canadian researchers, strengthens communities with the right tools and information, and translates research findings into early diagnostic, preventative, and therapeutic strategies for children with neurological disorders to live healthier lives. Currently, the network''s research focuses on autism spectrum disorder, cerebral palsy, and fetal alcohol spectrum disorder. These demonstration projects are supported by NeuroDevNet''s central infrastructure and cores, including Neuroethics, Neuroinformatics, and Knowledge Translation.

Proper citation: NeuroDevNet (RRID:SCR_004925) Copy   

•   Source: SciCrunch Registry
  

http://nimh-repository.rti.org/

A program that synthesizes, purifies, and distributes otherwise unavailable essential compounds to stimulate basic and clinical research in psychopharmacology relevant to mental health in areas such as the molecular pharmacology and signaling of CNS receptors, longitudinal studies to evaluate the molecular, biochemical, and behavioral actions of psychoactive compounds, and functional brain imaging in both primates and humans. WHAT IS AVAILABLE: * Ligands for CNS receptors, radiolabeled compounds for autoradiography and neuroimaging, biochemical markers, drug analogs and metabolites, and reference standards * Synthesis (including GMP) of promising compounds for mental health research, including preclinical toxicology and safety studies, especially compounds for PET neuroimaging * A listing of currently available NIMH CSDSP compounds is available online at www.nimh-repository.rti.org. RTI International scientists can provide investigators with technical assistance and additional information about the compounds on request. Data sheets containing purity, storage, and handling information are supplied with all NIMH CSDSP compounds. WHO IS ELIGIBLE: Investigators involved in basic or clinical research relevant to mental health are eligible to submit requests. To learn more about current NIMH research areas, please visit the NIMH website at www.nimh.nih.gov. NIMH CSDSP compounds are free to qualified academic investigators, but payment may be required from nonacademic requestors. Investigators interested in obtaining radiolabeled compounds but uncertain about what type of label or specific activity would work best for them may obtain help by communicating with the technical contacts listed on the website.

Proper citation: NIMH Chemical Synthesis and Drug Supply Program (RRID:SCR_004921) Copy   

•   Source: SciCrunch Registry
  

http://www.loni.usc.edu/Software/LONI-Inspector

A Java application for reading, displaying, searching, comparing, and exporting metadata from medical image files: AFNI, ANALYZE, DICOM, ECAT, GE, Interfile, MINC, and NIFTI.

Proper citation: LONI Inspector (RRID:SCR_004923) Copy   

•   Source: SciCrunch Registry
  

https://github.com/ABCD-STUDY/DEAP

Web service for data exploration and analysis of the ABCD Study - the largest long-term study of brain development and child health in the United States.

Proper citation: DEAP - Data Exploration and Analysis Portal (RRID:SCR_016158) Copy   

•   Source: SciCrunch Registry
  

https://github.com/brain-life/encode

Software that implements a framework to encode structural brain connectomes into multidimensional arrays (tensors). Encoding Connectomes provides an agile framework for computing over connectome edges and nodes.

Proper citation: Linear Fascicle Evaluation (RRID:SCR_016153) Copy   

•   Source: SciCrunch Registry
  

https://github.com/CAMI-challenge/AMBER

Software toolkit for the comparative assessment of genome reconstructions from metagenome benchmark datasets. It provides performance metrics, results rankings, and comparative visualizations for assessing multiple programs or parameter effects.

Proper citation: AMBER (RRID:SCR_016151) Copy   

•   Source: SciCrunch Registry
  

https://nemoarchive.org/

Data repository specifically focused on storage and dissemination of omic data generated from BRAIN Initiative and related brain research projects. Data repository and archive for BCDC and BICCN project, among others. NeMO data include genomic regions associated with brain abnormalities and disease, transcription factor binding sites and other regulatory elements, transcription activity, levels of cytosine modification, histone modification profiles and chromatin accessibility.

Proper citation: NeMOarchive (RRID:SCR_016152) Copy   

•   Source: SciCrunch Registry
  

https://hirnetwork.org/consortium/ctar

Consortium that is an independent research initiative of the Human Research Information Network (HIRN). It is investigating methods to increase or maintain functional beta cell mass in T1D through targeted manipulation of islet plasticity or engineered protection of beta cells from immune-mediated destruction.

Proper citation: HIRN Consortium on Targeting and Regeneration (RRID:SCR_016201) Copy   

•   Source: SciCrunch Registry
  

http://hyphy.org/

Open source software package for comparative sequence analysis using stochastic evolutionary models. Used for analysis of genetic sequence data in particular the inference of natural selection using techniques in phylogenetics, molecular evolution, and machine learning.

Proper citation: HyPhy (RRID:SCR_016162) Copy   

•   Source: SciCrunch Registry
  

http://abacus.gene.ucl.ac.uk/software/indelible/

Software that generates nucleotide, amino acid and codon sequence data by simulating insertions and deletions (indels) as well as substitutions. It is used for biological sequence simulation of multi-partitioned nucleotide, amino-acid, or codon data sets through the processes of insertion, deletion, and substitution in continuous time.

Proper citation: Indelible (RRID:SCR_016163) Copy   

•   Source: SciCrunch Registry
  

https://github.com/sdparekh/zUMIs

Software pipeline to process RNA-seq data with UMIs. The input to this pipeline is paired-end fastq files, where one read contains the cDNA sequence and the other read contains UMI and Cell Barcode information.

Proper citation: zUMIs (RRID:SCR_016139) Copy   

•   Source: SciCrunch Registry
  

https://www.microsoft.com/en-gb/

Software application with data analysis tools and spreadsheet templates to track and visualize data. It is used to manage and process data.

Proper citation: Microsoft Excel (RRID:SCR_016137) Copy   

•   Source: SciCrunch Registry
  

http://fastml.tau.ac.il/

Web application for the reconstruction of ancestral sequences. It computes maximum likelihood ancestral sequence reconstruction based on the phylogenetic relations between homologous sequences.

Proper citation: Fastml (RRID:SCR_016092) Copy   

•   Source: SciCrunch Registry
  

https://sanger-pathogens.github.io/gubbins/

Software application as an algorithm that iteratively identifies loci containing elevated densities of base substitutions while concurrently constructing a phylogeny based on the putative point mutations outside of these regions. It is used for phylogenetic analysis of genome sequences and generating highly accurate reconstructions under realistic models of short-term bacterial evolution., THIS RESOURCE IS NO LONGER IN SERVICE. Documented on September 16,2025.

Proper citation: Gubbins (RRID:SCR_016131) Copy   

•   Source: SciCrunch Registry
  

http://www.medibeacon.com/preclinical/

Software used to analyze glomerular filtration rate (GFR) measurement from MediBeacon GFR monitor. It is used with the Transdermal Continuous Renal Function Monitor.

Proper citation: MediBeacon Studio Software (RRID:SCR_016252) Copy   

•   Source: SciCrunch Registry